BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26185006)

  • 1. Synthesis and evaluation of isatin-β-thiosemicarbazones as novel agents against antibiotic-resistant Gram-positive bacterial species.
    Zhang XM; Guo H; Li ZS; Song FH; Wang WM; Dai HQ; Zhang LX; Wang JG
    Eur J Med Chem; 2015 Aug; 101():419-30. PubMed ID: 26185006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones.
    Thanh ND; Giang NTK; Quyen TH; Huong DT; Toan VN
    Eur J Med Chem; 2016 Nov; 123():532-543. PubMed ID: 27517802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
    Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
    ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
    Sharma M; Manhas RK
    BMC Microbiol; 2019 Feb; 19(1):44. PubMed ID: 30782119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Constituents from
    Muhammad I; Jacob MR; Ibrahim MA; Raman V; Kumarihamy M; Wang M; Al-Adhami T; Hind C; Clifford M; Martin B; Zhao J; Sutton JM; Rahman KM
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33352963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
    Shokri D; Zaghian S; Khodabakhsh F; Fazeli H; Mobasherizadeh S; Ataei B
    J Microbiol Immunol Infect; 2014 Oct; 47(5):371-6. PubMed ID: 23838264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of 5'-C-piperidinyl-5'-O-aminoribosyluridines as potential antibacterial agents.
    Nakaya T; Matsuda A; Ichikawa S
    Org Biomol Chem; 2015 Jul; 13(28):7720-35. PubMed ID: 26090936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities.
    Okamura S; Nishiyama E; Yamazaki T; Otsuka N; Taniguchi S; Ogawa W; Hatano T; Tsuchiya T; Kuroda T
    Biochim Biophys Acta; 2015 Jun; 1850(6):1245-52. PubMed ID: 25731981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycyclic Polyprenylated Acylphloroglucinols: An Emerging Class of Non-Peptide-Based MRSA- and VRE-Active Antibiotics.
    Guttroff C; Baykal A; Wang H; Popella P; Kraus F; Biber N; Krauss S; Götz F; Plietker B
    Angew Chem Int Ed Engl; 2017 Dec; 56(50):15852-15856. PubMed ID: 28985019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents.
    Siddiqui AM; Sattigeri JA; Javed K; Shafi S; Shamim M; Singhal S; Malik ZM
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1198-1206. PubMed ID: 29525219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, anti-MRSA, and anti-VRE activity of hemin conjugates with amino acids and branched peptides.
    Okorochenkov SA; Zheltukhina GA; Mirchink EP; Isakova EB; Feofanov AV; Nebolsin VE
    Chem Biol Drug Des; 2013 Oct; 82(4):410-7. PubMed ID: 23663365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
    Honeyman L; Ismail M; Nelson ML; Bhatia B; Bowser TE; Chen J; Mechiche R; Ohemeng K; Verma AK; Cannon EP; Macone A; Tanaka SK; Levy S
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7044-53. PubMed ID: 26349824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of daptomycin against VRE and MRSA strains].
    Aktaş G; Derbentli S
    Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1.
    Bremner JB; Keller PA; Pyne SG; Boyle TP; Brkic Z; David DM; Robertson M; Somphol K; Baylis D; Coates JA; Deadman J; Jeevarajah D; Rhodes DI
    Bioorg Med Chem; 2010 Apr; 18(7):2611-20. PubMed ID: 20236828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure optimizing of flavonoids against both MRSA and VRE.
    Wei MZ; Zhu YY; Zu WB; Wang H; Bai LY; Zhou ZS; Zhao YL; Wang ZJ; Luo XD
    Eur J Med Chem; 2024 May; 271():116401. PubMed ID: 38640870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.